Imprimis Pharma (IMMY)

2.40 +0.04 (1.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Form 8-K Imprimis Pharmaceuticals For: Jun 01 June 1, 2018 7:01 AM - SEC Filing ImprimisRx's DroplessĀ® Steroid and Antibiotic Intravitreal Injection Featured in the Prestigious Journal of Cataract and Refractive Surgery May 30, 2018 7:30 AM - PR NewsWire Form 8-K Imprimis Pharmaceuticals For: May 15 May 15, 2018 5:47 PM - SEC Filing Form 10-Q Imprimis Pharmaceuticals For: Mar 31 May 15, 2018 5:47 PM - SEC Filing Imprimis Pharma (IMMY) Reports Q1 Revenues Above Estimates May 15, 2018 4:02 PM - StreetInsider Imprimis Pharmaceuticals Announces First Quarter 2018 Results May 15, 2018 4:01 PM - PR NewsWire Imprimis Pharma (IMMY) Affiliate Surface Pharmaceuticals Announces $20 Million Series A Financing from Flying L Partners May 15, 2018 7:32 AM - StreetInsider Form 8-K Imprimis Pharmaceuticals For: Sep 28 May 15, 2018 7:31 AM - SEC Filing Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners May 15, 2018 7:30 AM - PR NewsWire Imprimis Pharmaceuticals to Host its First Quarter 2018 Financial Report Conference Call and Webcast on May 15, 2018 at 4:30 p.m. EDT May 2, 2018 7:30 AM - Globe NewsWire Imprimis Pharmaceuticals to Host its First Quarter 2018 Financial Report Conference Call and Webcast on May 15, 2018 at 4:30 p.m. EDT May 2, 2018 7:30 AM - StreetInsider Form DEF 14A Imprimis Pharmaceuticals For: Apr 30 April 30, 2018 6:28 PM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Apr 10 April 13, 2018 8:01 AM - SEC Filing Form PRE 14A Imprimis Pharmaceuticals For: Apr 12 April 12, 2018 4:39 PM - SEC Filing Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO MeltĀ® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & April 10, 2018 7:30 AM - PR NewsWire Imprimis Pharma (IMMY) Secures Composition Patent for Non-Opioid Conscious Sedation Formulation March 27, 2018 7:34 AM - StreetInsider Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation March 27, 2018 7:30 AM - PR NewsWire Full Article List